US Stocks
/
Skye Bioscience, Inc. Share Price

Skye Bioscience, Inc. Share Price

NASDAQ: SKYE
$0.00
+0.00 (0.00%)
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Skye Bioscience, Inc. Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
N/A
Volume
N/A
Average Traded
N/A

Skye Bioscience, Inc. Share Price Chart

$0.00$0.00
L
Show Current Price
H

Skye Bioscience, Inc. Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
$-1.41
Revenue (TTM)
N/A
Return On Equity (TTM)
-279.29%
Profit Margin
N/A
Debt to Equity
0.41
Quarterly Earnings Growth YoY
-227.19%

Skye Bioscience, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/AN/AN/A
Net Profit-$5.02M-$7.90M-$3.90M-$11.10M-$17.62M-$12.75M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A-57.44%50.67%-184.82%-58.74%27.63%

Skye Bioscience, Inc. Annual Profit & Loss

All figures in USD

Particulars20212022202320242025
RevenueN/AN/AN/AN/AN/A
Net Profit-$8.52M-$19.48M-$37.64M-$26.57M-$55.92M
Net Profit MarginN/AN/AN/AN/AN/A
Income ChangeN/A-128.60%-93.23%29.43%-110.50%

About Skye Bioscience, Inc.

Skye Bioscience, Inc., a clinical stage biopharmaceutical company, focuses on developing molecules that modulate G protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. The company is headquartered in San Diego, California.

Skye Bioscience, Inc. Historical Returns

MonthOpenCloseChange %

SKYE Share Price FAQs

What is Skye Bioscience, Inc. share price today?

chevron-up
Skye Bioscience, Inc. share price today is $0.00 as on August 9, 2026 at 2:11 pm IST.

What is the 52 week high and 52 week low of Skye Bioscience, Inc. stock?

chevron-up
52 week high/low data for Skye Bioscience, Inc. is currently unavailable.

What is SKYE's net income for the last quarter?

chevron-up
SKYE's net income for the last quarter is -0.01B USD.

Can I buy SKYE shares in India?

chevron-up
Yes. You can buy SKYE in India by opening an international trading account.